Generic drug crisis in Japan and changes leading to the collapse of universal health insurance established in 1961: the case of Kobayashi Kako Co. Ltd

Cost Eff Resour Alloc. 2023 May 31;21(1):35. doi: 10.1186/s12962-023-00441-z.

Makoto Kosaka¹, Akihiko Ozaki^{2

3}, Yudai Kaneda⁴, Hiroaki Saito², Erika Yamashita², Anju Murayama⁵, Hanano Mamada², Tetsuya Tanimoto², Mihajlo Jakovljevic^{6

7

8}

¹ Imamura Hospital Kagoshima, Kagoshima, Japan.
² Medical Governance Research Institute, Minato-ku, Tokyo, Japan.
³ Department of Breast and Thryoid Surgery, Jyoban Hospital of Tokiwa Foundation, Iwaki, Fukushima, Japan.
⁴ School of Medicine, Hokkaido University, Sapporo, Hokkaido, Japan.
⁵ School of Medicine, Tohoku University, Sendai, Miyagi, Japan.
⁶ Institute of Advanced Manufacturing Technologies, Peter the Great St. Petersburg Polytechnic University, St. Petersburg, Russia. sidartagothama@gmail.com.
⁷ Institute of Comparative Economic Studies, Hosei University, Chiyoda-ku, Tokyo, Japan. sidartagothama@gmail.com.
⁸ Department of Global Health Economics and Policy, University of Kragujevac, Kragujevac, Serbia. sidartagothama@gmail.com.

No abstract available

Publication types